Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5632)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2024 (publication date) through Dec 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Guo AJ, Deng QY, Dong P, Zhou L, Shi L. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors. World J Clin Oncol 2024; 15(8): 1002-1020 [PMID: 39193157 DOI: 10.5306/wjco.v15.i8.1002] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Guo AJ, Deng QY, Dong P, Zhou L, Shi L. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors. World J Clin Oncol 2024; 15(8): 1002-1020 [PMID: 39193157 DOI: 10.5306/wjco.v15.i8.1002] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i8/1002.htm |
| Number | Citing Articles |
| 1 |
Jasmine Vohra, Gabriela Barbosa, Lívia Bitencourt Pascoal, Leonardo O. Reis. Advances in Genitourinary Tumor Genomics and Immunotherapy. Genes 2025; 16(6): 667 doi: 10.3390/genes16060667
|
| 2 |
Marco Agostini, Pietro Traldi, Mahmoud Hamdan. The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. Journal of Personalized Medicine 2025; 15(12): 596 doi: 10.3390/jpm15120596
|
| 3 |
Yuanqiang Sun, Ziyang Zhang, Ke Jia, Hong Liu, Furen Zhang. Autoimmune-related adverse events induced by immune checkpoint inhibitors. Current Opinion in Immunology 2025; 94: 102556 doi: 10.1016/j.coi.2025.102556
|
| 4 |
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, Eleni-Myrto Trifylli, Dimitris Liapopoulos, Dimitra Korakaki, Evangelos Koustas, Michalis Katsimpoulas, Michalis V. Karamouzis. Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma. Cancers 2025; 17(3): 555 doi: 10.3390/cancers17030555
|
| 5 |
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo. The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. Med Research 2025; 1(3): 322 doi: 10.1002/mdr2.70019
|
| 6 |
Saeed Zivari Lashkajani, Yasaman Sadat Azad, Mohammad Taha Nami, Ali Darzi, Mahla shokouhfar, Sina Naddaf faizabadi, Maryam Diansaei, Komeil Aghazadeh-Habashi, Zahra Azimzadeh Tabrizi, Ahmad Ghorbani Vanan. Neurologic complications of immune checkpoint inhibitors: A comprehensive review. Biomedicine & Pharmacotherapy 2025; 192: 118669 doi: 10.1016/j.biopha.2025.118669
|
| 7 |
Feilong Tan, Li Zhou, Guijiang Huang, Yanhua Li, Wenjie Yin, Hongying Xia. Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database. Oncology 2025; 103(12): 1147 doi: 10.1159/000543520
|
| 8 |
Franciszek Kaczmarek, Anna Marcinkowska-Gapińska, Joanna Bartkowiak-Wieczorek, Michał Nowak, Michał Kmiecik, Kinga Brzezińska, Mariusz Dotka, Paweł Brosz, Wojciech Firlej, Paulina Wojtyła-Buciora. Blood-Based Biomarkers as Predictive and Prognostic Factors in Immunotherapy-Treated Patients with Solid Tumors—Currents and Perspectives. Cancers 2025; 17(12): 2001 doi: 10.3390/cancers17122001
|